-+ 0.00%
-+ 0.00%
-+ 0.00%

What Darling Ingredients Had To Prove And It Was Not Revenue

Simply Wall St·10/03/2026 15:25:05
语音播报

If you held Darling Ingredients through this year, the result now looks hard to ignore. For Darling Ingredients shareholders, the return from the start of the year was 67.2%, including dividends. If you had been weighing a position back on 1 January 2026, you would have been staring at clashing analyst views on biofuel policy, collagen potential, and regulatory risk. Which pieces of that debate were solid facts and which were hopes dressed up as forecasts?

Darling Ingredients has already moved. See which of 31 high quality undervalued stocks still trade below our estimates.

The Argument You Would Have Been Weighing On Darling Ingredients

The shares cost US$36 at the start, and anyone looking at Darling Ingredients then had to choose between two very different stories about the same business.

On the upbeat side, the bullish Narrative said the stock was worth a Fair Value of US$60, a price implied by strong assumptions, built on decarbonization, premium collagen demand, and higher margins from a leading feedstock position.

The cautious Narrative put Fair Value at US$34, tied to worries that regulatory uncertainty, high compliance costs, and heavy investment needs could restrain margins and slow earnings progress.

NYSE:DAR Trailing 12-Month Earnings & Revenue History as at Oct 2026
NYSE:DAR Trailing 12-Month Earnings & Revenue History as at Oct 2026

What The Results Changed For Darling Ingredients

Q2 2026 gave Darling Ingredients bulls fresh support when revenue reached US$1.72b and net income rose to US$387.3m, lifting net margin from 0.9% to 22.5%. That swing echoed earlier 2026 quarters where management highlighted stronger DGD profitability, collagen demand, and policy support. Bears still had something to point to in prior multi year revenue and earnings contraction, so the evidence cut both ways.

The clear hinge here was margin quality. For any similar stock, track whether higher margins show up in sustained net income and cash generation rather than only in presentations or guidance.

What Darling Ingredients' Run Has Already Priced In

Darling Ingredients now trades at US$62.94, and this Narrative argues that its Fair Value remains above that level. The focus is on how far current operations and capital decisions can support that claim rather than on the past share price move.

The Narrative leans on stronger margins, renewable diesel economics, and wider product exposure. A buyer here has to judge whether sustained profitability at DGD and continued waste oil strength are realistic for long enough to support that higher figure.

"Improved renewable diesel economics and strengthening waste oil markets are viewed as important supports for earnings quality and cash flow, especially given the company’s exposure to these segments. Several bullish analysts reference supportive policy environments and global diesel tightness as positive for volume and margin assumptions, which they see as consistent with higher P/E expectations."

Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there

Find Your Own Contrarian Opportunity

What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.

  • Company 1 - 36% below our estimate - leans on a large backlog tied to data-centric infrastructure activity.
  • Company 2 - 23% below our estimate - targets expanding data centre budgets driven by rising AI hardware and software demand.
  • Company 3 - 34% below our estimate - converts a growing pipeline of AI-linked modular projects into installation-focused utilisation.

Those are three of them. See every one of the 26 solid balance sheet companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.